Report Detail

Other Global Glaucoma Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3680777
  • |
  • 19 August, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible.

Scope of the Report:
In the last several years, Hong Kong market of Glaucoma Treatment developed rapidly, with an average growth rate of 4% during 2013 to 2018. In 2018, Hong Kong revenue of Glaucoma Treatment is nearly 73 M USD.
The classification of Glaucoma Treatment includes Prostaglandin Analogs (PGAs), Beta Blocker, Alpha Agonist and other, and the proportion of Prostaglandin Analogs (PGAs) in 2018 is about 52%, and the proportion is in increasing trend from 2013 to 2018.
Glaucoma Treatment is widely used in Clinic, Pharmacy and other field. The most proportion of Glaucoma Treatment is in hospitals, and the proportion in 2018 is 66%.
The global Glaucoma Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Glaucoma Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Glaucoma Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Glaucoma Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist

Market Segment by Applications, can be divided into
Clinic
Pharmacy
Other


Table of Contents

    1 Glaucoma Treatment Market Overview

    • 1.1 Product Overview and Scope of Glaucoma Treatment
    • 1.2 Classification of Glaucoma Treatment by Types
      • 1.2.1 Global Glaucoma Treatment Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Glaucoma Treatment Revenue Market Share by Types in 2018
      • 1.2.3 Prostaglandin Analogs (PGAs)
      • 1.2.4 Beta Blocker
      • 1.2.5 Alpha Agonist
    • 1.3 Global Glaucoma Treatment Market by Application
      • 1.3.1 Global Glaucoma Treatment Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Clinic
      • 1.3.3 Pharmacy
      • 1.3.4 Other
    • 1.4 Global Glaucoma Treatment Market by Regions
      • 1.4.1 Global Glaucoma Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Glaucoma Treatment Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Glaucoma Treatment Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Glaucoma Treatment Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Glaucoma Treatment Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Glaucoma Treatment Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Glaucoma Treatment (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Novartis
      • 2.1.1 Business Overview
      • 2.1.2 Glaucoma Treatment Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Novartis Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Allergan
      • 2.2.1 Business Overview
      • 2.2.2 Glaucoma Treatment Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Allergan Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Pfizer
      • 2.3.1 Business Overview
      • 2.3.2 Glaucoma Treatment Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Pfizer Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Akorn
      • 2.4.1 Business Overview
      • 2.4.2 Glaucoma Treatment Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Akorn Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Teva
      • 2.5.1 Business Overview
      • 2.5.2 Glaucoma Treatment Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Teva Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Bausch & Lomb
      • 2.6.1 Business Overview
      • 2.6.2 Glaucoma Treatment Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Bausch & Lomb Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Otsuka Pharmaceutical
      • 2.7.1 Business Overview
      • 2.7.2 Glaucoma Treatment Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Otsuka Pharmaceutical Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Santen
      • 2.8.1 Business Overview
      • 2.8.2 Glaucoma Treatment Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Santen Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Lunan Pharma
      • 2.9.1 Business Overview
      • 2.9.2 Glaucoma Treatment Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Lunan Pharma Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Zizhu Pharma
      • 2.10.1 Business Overview
      • 2.10.2 Glaucoma Treatment Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Zizhu Pharma Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Glaucoma Treatment Market Competition, by Players

    • 3.1 Global Glaucoma Treatment Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Glaucoma Treatment Players Market Share
      • 3.2.2 Top 10 Glaucoma Treatment Players Market Share
    • 3.3 Market Competition Trend

    4 Global Glaucoma Treatment Market Size by Regions

    • 4.1 Global Glaucoma Treatment Revenue and Market Share by Regions
    • 4.2 North America Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 4.5 South America Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Glaucoma Treatment Revenue and Growth Rate (2014-2019)

    5 North America Glaucoma Treatment Revenue by Countries

    • 5.1 North America Glaucoma Treatment Revenue by Countries (2014-2019)
    • 5.2 USA Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Glaucoma Treatment Revenue and Growth Rate (2014-2019)

    6 Europe Glaucoma Treatment Revenue by Countries

    • 6.1 Europe Glaucoma Treatment Revenue by Countries (2014-2019)
    • 6.2 Germany Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 6.3 UK Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 6.4 France Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Glaucoma Treatment Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Glaucoma Treatment Revenue by Countries

    • 7.1 Asia-Pacific Glaucoma Treatment Revenue by Countries (2014-2019)
    • 7.2 China Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 7.5 India Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Glaucoma Treatment Revenue and Growth Rate (2014-2019)

    8 South America Glaucoma Treatment Revenue by Countries

    • 8.1 South America Glaucoma Treatment Revenue by Countries (2014-2019)
    • 8.2 Brazil Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Glaucoma Treatment Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Glaucoma Treatment by Countries

    • 9.1 Middle East and Africa Glaucoma Treatment Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Glaucoma Treatment Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Glaucoma Treatment Revenue and Growth Rate (2014-2019)

    10 Global Glaucoma Treatment Market Segment by Type

    • 10.1 Global Glaucoma Treatment Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Glaucoma Treatment Market Forecast by Type (2019-2024)
    • 10.3 Prostaglandin Analogs (PGAs) Revenue Growth Rate (2014-2024)
    • 10.4 Beta Blocker Revenue Growth Rate (2014-2024)
    • 10.5 Alpha Agonist Revenue Growth Rate (2014-2024)

    11 Global Glaucoma Treatment Market Segment by Application

    • 11.1 Global Glaucoma Treatment Revenue Market Share by Application (2014-2019)
    • 11.2 Glaucoma Treatment Market Forecast by Application (2019-2024)
    • 11.3 Clinic Revenue Growth (2014-2019)
    • 11.4 Pharmacy Revenue Growth (2014-2019)
    • 11.5 Other Revenue Growth (2014-2019)

    12 Global Glaucoma Treatment Market Size Forecast (2019-2024)

    • 12.1 Global Glaucoma Treatment Market Size Forecast (2019-2024)
    • 12.2 Global Glaucoma Treatment Market Forecast by Regions (2019-2024)
    • 12.3 North America Glaucoma Treatment Revenue Market Forecast (2019-2024)
    • 12.4 Europe Glaucoma Treatment Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Glaucoma Treatment Revenue Market Forecast (2019-2024)
    • 12.6 South America Glaucoma Treatment Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Glaucoma Treatment Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Glaucoma Treatment. Industry analysis & Market Report on Glaucoma Treatment is a syndicated market report, published as Global Glaucoma Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Glaucoma Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,756.16
      4,134.24
      5,512.32
      3,215.52
      4,823.28
      6,431.04
      526,489.20
      789,733.80
      1,052,978.40
      290,127.60
      435,191.40
      580,255.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report